Theodore Iliopoulos
Operationeel Directeur bij Polpharma SA
Profiel
Theodore Iliopoulos is currently working as the Vice President-Operations at Polpharma SA since 2002.
Previously, he held the position of Principal at Bristol Myers Squibb Co. and Vice President-Operations at Patheon, Inc. Mr. Iliopoulos completed his undergraduate degree from the National & Kapodistrian University of Athens in 1970.
Actieve functies van Theodore Iliopoulos
| Bedrijven | Functie | Begin |
|---|---|---|
Polpharma SA
 Polpharma SA Pharmaceuticals: MajorHealth Technology Polpharma SA develops and manufactures generic drugs. It offers food for special medical purposes, on prescription, no prescription, and medical products. The company was founded in 1935 and is headquartered in Starogard Gdanski, Poland. | Operationeel Directeur | 01-01-2002 |
Eerdere bekende functies van Theodore Iliopoulos
| Bedrijven | Functie | Einde |
|---|---|---|
| PATHEON, INC. | Operationeel Directeur | - |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | - |
Opleiding van Theodore Iliopoulos
| National & Kapodistrian University of Athens | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
Polpharma SA
Polpharma SA Pharmaceuticals: MajorHealth Technology Polpharma SA develops and manufactures generic drugs. It offers food for special medical purposes, on prescription, no prescription, and medical products. The company was founded in 1935 and is headquartered in Starogard Gdanski, Poland. | Health Technology |
Patheon, Inc.
 Patheon, Inc. Pharmaceuticals: MajorHealth Technology Patheon, Inc. provides drug development and manufacturing services to global pharmaceutical, biotechnology and specialty pharmaceutical companies. It operates through two segments: Commercial Manufacturing Outsourcing and Pharmaceutical Development Services. The Commercial Manufacturing Outsourcing segment manufactures prescription products in sterile dosage forms as well as solid and liquid conventional dosage forms. The Pharmaceutical Development Services segment provides a broad range of development services, including solid and sterile dosage forms. The company operates through four market segments: Biologics, Emerging Pharma, Generics and Large Pharma. Patheon was founded in 1974 and is headquartered in Mississauga, Canada. | Health Technology |
